ROBERT F APPLE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT F APPLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT F APPLE. ROBERT F APPLE is Executive Vice President & COO in ANTARES PHARMA, INC. ($ATRS) and President & CEO in ANTARES PHARMA, INC. ($ATRS).
Latest Insider Trading Transactions of ROBERT F APPLE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 0.88 | 250,000 | 220,000 | 0 | |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 5,519 | 14,460 | 0 | |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 5.00 | 241,960 | 1,209,800 | 2,204,760 | 2.4 M to 2.2 M (-9.89 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 5.01 | 17,844 | 89,398 | 2,446,720 | 2.5 M to 2.4 M (-0.72 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 5.00 | 232,156 | 1,160,780 | 2,464,564 | 2.7 M to 2.5 M (-8.61 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 0.88 | 250,000 | 220,000 | 2,696,720 | 2.4 M to 2.7 M (+10.22 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 5,519 | 26,215 | 2,446,720 | 2.5 M to 2.4 M (-0.23 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 5,519 | 14,460 | 2,452,239 | 2.4 M to 2.5 M (+0.23 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 4.73 | 116,313 | 550,160 | 2,446,720 | 2.6 M to 2.4 M (-4.54 %) |
Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 0.00 | 267,878 | 0 | 2,563,033 | 2.3 M to 2.6 M (+11.67 %) |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 7,278 | 19,068 | 0 | |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 49,129 | 128,718 | 0 | |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.62 | 33,574 | 87,964 | 0 | |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 7,278 | 34,571 | 2,295,155 | 2.3 M to 2.3 M (-0.32 %) |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 7,278 | 19,068 | 2,302,433 | 2.3 M to 2.3 M (+0.32 %) |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 49,129 | 233,363 | 2,295,155 | 2.3 M to 2.3 M (-2.10 %) |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 49,129 | 128,718 | 2,344,284 | 2.3 M to 2.3 M (+2.14 %) |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 33,574 | 159,477 | 2,295,155 | 2.3 M to 2.3 M (-1.44 %) |
Feb 10 2021 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.62 | 33,574 | 87,964 | 2,328,729 | 2.3 M to 2.3 M (+1.46 %) |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.73 | 776,617 | 2,120,164 | 776,617 | |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.78 | 40,892 | 113,680 | 2,295,155 | 2.3 M to 2.3 M (-1.75 %) |
Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.73 | 402,930 | 1,099,999 | 2,336,047 | 1.9 M to 2.3 M (+20.84 %) |
Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.13 | 44,223 | 138,418 | 1,933,117 | 2 M to 1.9 M (-2.24 %) |
Jun 09 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.12 | 48,936 | 152,680 | 1,977,340 | 2 M to 2 M (-2.42 %) |
Feb 21 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.53 | 90,397 | 319,101 | 2,026,276 | 2.1 M to 2 M (-4.27 %) |
Feb 21 2020 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 0.00 | 210,782 | 0 | 2,116,673 | 1.9 M to 2.1 M (+11.06 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 3.96 | 58,524 | 231,755 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 3.96 | 1,000 | 3,960 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 2.94 | 110,000 | 323,400 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.66 | 97,000 | 161,020 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.52 | 100,000 | 152,000 | 0 | |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.76 | 58,524 | 278,358 | 1,905,891 | 2 M to 1.9 M (-2.98 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 3.96 | 58,524 | 231,755 | 1,964,415 | 1.9 M to 2 M (+3.07 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.75 | 1,000 | 4,750 | 1,905,891 | 1.9 M to 1.9 M (-0.05 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 3.96 | 1,000 | 3,960 | 1,906,891 | 1.9 M to 1.9 M (+0.05 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.58 | 110,000 | 503,426 | 1,905,891 | 2 M to 1.9 M (-5.46 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 2.94 | 110,000 | 323,400 | 2,015,891 | 1.9 M to 2 M (+5.77 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.62 | 97,000 | 448,412 | 1,905,891 | 2 M to 1.9 M (-4.84 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.66 | 97,000 | 161,020 | 2,002,891 | 1.9 M to 2 M (+5.09 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 4.68 | 100,000 | 467,830 | 1,905,891 | 2 M to 1.9 M (-4.99 %) |
Dec 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.52 | 100,000 | 152,000 | 2,005,891 | 1.9 M to 2 M (+5.25 %) |
Nov 13 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.10 | 100,000 | 110,000 | 0 | |
Nov 13 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.77 | 43,445 | 163,788 | 1,905,891 | 1.9 M to 1.9 M (-2.23 %) |
Nov 13 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.10 | 100,000 | 110,000 | 1,949,336 | 1.8 M to 1.9 M (+5.41 %) |
Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.92 | 567,423 | 1,656,875 | 567,423 | |
Jun 14 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.92 | 282,534 | 824,999 | 1,849,336 | 1.6 M to 1.8 M (+18.03 %) |
Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.81 | 44,225 | 124,272 | 1,566,802 | 1.6 M to 1.6 M (-2.75 %) |
Jun 11 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.81 | 48,936 | 137,510 | 1,611,027 | 1.7 M to 1.6 M (-2.95 %) |
Jun 04 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.79 | 52,559 | 146,640 | 1,659,963 | 1.7 M to 1.7 M (-3.07 %) |
Feb 22 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 3.20 | 72,245 | 231,184 | 1,712,522 | 1.8 M to 1.7 M (-4.05 %) |
Feb 22 2019 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 0.00 | 254,205 | 0 | 1,784,767 | 1.5 M to 1.8 M (+16.61 %) |
Aug 23 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 0.47 | 43,000 | 20,210 | 0 | |
Aug 23 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 3.75 | 43,000 | 161,250 | 1,530,562 | 1.6 M to 1.5 M (-2.73 %) |
Aug 23 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 0.47 | 43,000 | 20,210 | 1,573,562 | 1.5 M to 1.6 M (+2.81 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.70 | 591,510 | 1,597,077 | 591,510 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.70 | 305,556 | 825,001 | 1,530,562 | 1.2 M to 1.5 M (+24.94 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.70 | 32,031 | 86,484 | 1,225,006 | 1.3 M to 1.2 M (-2.55 %) |
Jun 05 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.69 | 34,402 | 92,541 | 1,257,037 | 1.3 M to 1.3 M (-2.66 %) |
May 30 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.43 | 13,480 | 32,756 | 1,291,439 | 1.3 M to 1.3 M (-1.03 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 0.85 | 82,500 | 70,125 | 0 | |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.52 | 30,052 | 75,731 | 1,304,919 | 1.3 M to 1.3 M (-2.25 %) |
May 14 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 0.85 | 82,500 | 70,125 | 1,334,971 | 1.3 M to 1.3 M (+6.59 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.66 | 725,751 | 1,930,498 | 725,751 | |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.66 | 338,115 | 899,386 | 1,175,637 | 1.5 M to 1.2 M (-22.34 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.57 | 38,034 | 97,747 | 837,522 | 875.6 K to 837.5 K (-4.34 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.51 | 3,390 | 8,509 | 875,556 | 878.9 K to 875.6 K (-0.39 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.51 | 14,903 | 37,407 | 878,946 | 893.8 K to 878.9 K (-1.67 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.37 | 1,763 | 4,178 | 893,849 | 895.6 K to 893.8 K (-0.20 %) |
Jun 09 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 0.00 | 5,612 | 0 | 895,612 | 890 K to 895.6 K (+0.63 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.65 | 3,000 | 4,950 | 0 | |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.65 | 37,000 | 61,050 | 3,000 | |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 3.00 | 3,000 | 9,000 | 890,002 | 893 K to 890 K (-0.34 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.65 | 3,000 | 4,950 | 893,002 | 890 K to 893 K (+0.34 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 3.00 | 37,000 | 111,070 | 890,002 | 927 K to 890 K (-3.99 %) |
Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.65 | 37,000 | 61,050 | 927,002 | 890 K to 927 K (+4.16 %) |
Dec 29 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.23 | 60,000 | 73,800 | 0 | |
Dec 29 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.35 | 39,717 | 93,335 | 890,002 | 929.7 K to 890 K (-4.27 %) |
Dec 29 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.23 | 60,000 | 73,800 | 929,719 | 869.7 K to 929.7 K (+6.90 %) |
Jun 30 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 1.05 | 11,223 | 11,784 | 869,719 | 858.5 K to 869.7 K (+1.31 %) |
Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 1.12 | 773,700 | 866,544 | 773,700 | |
Jun 06 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 1.12 | 363,150 | 406,728 | 858,496 | 495.3 K to 858.5 K (+73.31 %) |
Jun 01 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 0.92 | 3,389 | 3,118 | 495,346 | 498.7 K to 495.3 K (-0.68 %) |
Jun 01 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 0.92 | 14,903 | 13,711 | 498,735 | 513.6 K to 498.7 K (-2.90 %) |
Jun 01 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 0.86 | 3,526 | 3,032 | 513,638 | 517.2 K to 513.6 K (-0.68 %) |
Mar 18 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | P | 0.72 | 60,000 | 43,200 | 517,164 | 457.2 K to 517.2 K (+13.12 %) |
Mar 11 2016 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 0.88 | 250,000 | 220,000 | 250,000 | |
Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 2.18 | 288,786 | 629,553 | 288,786 | |
Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Grant | A | 0.00 | 142,294 | 0 | 457,164 | 314.9 K to 457.2 K (+45.19 %) |
Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Payment of Exercise | F | 2.18 | 3,389 | 7,388 | 314,870 | 318.3 K to 314.9 K (-1.06 %) |
Jun 01 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Payment of Exercise | F | 2.10 | 3,526 | 7,405 | 318,259 | 321.8 K to 318.3 K (-1.10 %) |
Mar 12 2015 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | Executive Vice Pres ... | Option Exercise | A | 2.62 | 95,500 | 250,210 | 95,500 |
Page: 1